Conrad Mir
Chief Executive Officer bei CALMARE THERAPEUTICS INCORPORATED
Profil
Conrad F.
Mir is currently the President, Chief Executive Officer & Director at Calmare Therapeutics, Inc. He is also the Chairman-Alumni Council at Tau Kappa Epsilon Fraternity, a Director at Aran Laboratories, a Director at O6 Technologies, Inc., and a Member of the National Investor Relations Institute.
Previously, he served as a Director at Genetic Immunity, Inc., the Executive Director-Business Development at Advaxis, Inc. from 2010 to 2011, and the Chief Financial Officer at Pressure BioSciences, Inc. from 2012 to 2013.
Mr. Mir completed his undergraduate degree at New York University.
Aktive Positionen von Conrad Mir
| Unternehmen | Position | Beginn |
|---|---|---|
| CALMARE THERAPEUTICS INCORPORATED | Chief Executive Officer | 27.09.2013 |
| Aran Laboratories | Director/Board Member | - |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Tau Kappa Epsilon Fraternity
 Tau Kappa Epsilon Fraternity Miscellaneous Commercial ServicesCommercial Services Tau Kappa Epsilon Fraternity operates as a social college fraternity association. The private company is based in Indianapolis, IN. | Corporate Officer/Principal | - |
| O6 Technologies, Inc. | Director/Board Member | - |
Ehemalige bekannte Positionen von Conrad Mir
| Unternehmen | Position | Ende |
|---|---|---|
| PRESSURE BIOSCIENCES, INC. | Director of Finance/CFO | 26.09.2013 |
| AYALA PHARMACEUTICALS, INC. | Public Communications Contact | 05.05.2010 |
Genetic Immunity, Inc.
 Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Director/Board Member | - |
Ausbildung von Conrad Mir
| New York University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Calmare Therapeutics, Inc.
 Calmare Therapeutics, Inc. Medical SpecialtiesHealth Technology Calmare Therapeutics, Inc. engages in the research, development, and commercialization of chronic, neuropathic pain and wound affliction devices. It offers licensing and technology sourcing. The company was founded in 1968 and is headquartered in Fairfield, CT. | Health Technology |
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Tau Kappa Epsilon Fraternity
Tau Kappa Epsilon Fraternity Miscellaneous Commercial ServicesCommercial Services Tau Kappa Epsilon Fraternity operates as a social college fraternity association. The private company is based in Indianapolis, IN. | Commercial Services |
| Aran Laboratories | |
| O6 Technologies, Inc. |
